By Bill Donahue (June 25, 2012, 7:41 PM EDT) -- Pfizer Inc. launched a sprawling patent war in Delaware federal court Monday, lodging separate lawsuits against 11 major pharmaceutical companies over the rival firms' efforts to market generic versions of the antidepressant drug Pristiq.
Pfizer and its Wyeth LLC subsidiary filed complaints against a slew of companies, such as Teva Pharmaceuticals USA Inc., Mylan Pharmaceuticals Inc., Watson Laboratories Inc., accusing each of infringing its patent for Pristiq by filing abbreviated new drug applications with the U.S. Food and Drug Administration.
One of the largest drugmakers in the world, Pfizer also leveled the claims at Anchen Pharmaceuticals Inc., Apotex Inc., Breckenridge Pharmaceutical...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!